Cognitive Function in Children with Lupus Nephritis: A Cross-Sectional Comparison with Children with Other Glomerular Chronic Kidney Diseases

Andrea Knight, Amy J. Kogon, Matthew B. Matheson, Bradley A. Warady, Susan L. Furth, Stephen R. Hooper

Research output: Contribution to journalArticle

Abstract

Objective: To identify factors contributing to cognitive impairment in children with lupus nephritis. Study design: A cross-sectional analysis of a large multicenter national cohort of children with chronic kidney disease (CKD) using standardized measures to determine baseline neuropsychiatric function and health-related quality of life (HRQoL) in children with lupus nephritis (n = 34), and to compare baseline function with that in children with other forms of glomerular CKD (gCKD; n = 171). We used inverse probability weighting via a logistic model for propensity score analysis to achieve balance between children with lupus nephritis and those with other glomerular causes of CKD, adjusting for known confounders. We used linear regression models to compare neurocognitive outcomes between exposure groups, adjusting for current prednisone use and testing for an interaction between current prednisone use and lupus nephritis, and to test for an association between cognitive function and HRQoL. Results: Current prednisone use was independently associated with worse attention (P < .01) and better adaptive skills (P = .04), and there was a significant interaction between current prednisone use and lupus nephritis for internalizing problems, with worse parent-reported internalizing problems in children with lupus nephritis on prednisone (P = .047). Better parent-reported HRQoL was associated with better visual memory (P = .01), and better child-reported HRQoL was associated with better attention (P < .01) and inhibitory control (P < .01). Both parent and child HRQoL were associated with better measures of executive function (P = .02 and < .001, respectively). Conclusion: Children with lupus nephritis have comparable or better cognitive function than their peers with other gCKDs, which is reassuring given the multiorgan and lifelong complications associated with lupus.

Original languageEnglish (US)
JournalJournal of Pediatrics
DOIs
StateAccepted/In press - 2017
Externally publishedYes

Fingerprint

Lupus Nephritis
Chronic Renal Insufficiency
Cognition
Prednisone
Quality of Life
Linear Models
Propensity Score
Executive Function
Cross-Sectional Studies
Logistic Models

Keywords

  • Adolescents
  • Chronic kidney disease
  • Glomerulonephritis
  • Health-related quality of life
  • Pediatric
  • Psychosocial

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Cognitive Function in Children with Lupus Nephritis : A Cross-Sectional Comparison with Children with Other Glomerular Chronic Kidney Diseases. / Knight, Andrea; Kogon, Amy J.; Matheson, Matthew B.; Warady, Bradley A.; Furth, Susan L.; Hooper, Stephen R.

In: Journal of Pediatrics, 2017.

Research output: Contribution to journalArticle

Knight, Andrea ; Kogon, Amy J. ; Matheson, Matthew B. ; Warady, Bradley A. ; Furth, Susan L. ; Hooper, Stephen R. / Cognitive Function in Children with Lupus Nephritis : A Cross-Sectional Comparison with Children with Other Glomerular Chronic Kidney Diseases. In: Journal of Pediatrics. 2017.
@article{8967e82785494e60bfb4c2863604bb1f,
title = "Cognitive Function in Children with Lupus Nephritis: A Cross-Sectional Comparison with Children with Other Glomerular Chronic Kidney Diseases",
abstract = "Objective: To identify factors contributing to cognitive impairment in children with lupus nephritis. Study design: A cross-sectional analysis of a large multicenter national cohort of children with chronic kidney disease (CKD) using standardized measures to determine baseline neuropsychiatric function and health-related quality of life (HRQoL) in children with lupus nephritis (n = 34), and to compare baseline function with that in children with other forms of glomerular CKD (gCKD; n = 171). We used inverse probability weighting via a logistic model for propensity score analysis to achieve balance between children with lupus nephritis and those with other glomerular causes of CKD, adjusting for known confounders. We used linear regression models to compare neurocognitive outcomes between exposure groups, adjusting for current prednisone use and testing for an interaction between current prednisone use and lupus nephritis, and to test for an association between cognitive function and HRQoL. Results: Current prednisone use was independently associated with worse attention (P < .01) and better adaptive skills (P = .04), and there was a significant interaction between current prednisone use and lupus nephritis for internalizing problems, with worse parent-reported internalizing problems in children with lupus nephritis on prednisone (P = .047). Better parent-reported HRQoL was associated with better visual memory (P = .01), and better child-reported HRQoL was associated with better attention (P < .01) and inhibitory control (P < .01). Both parent and child HRQoL were associated with better measures of executive function (P = .02 and < .001, respectively). Conclusion: Children with lupus nephritis have comparable or better cognitive function than their peers with other gCKDs, which is reassuring given the multiorgan and lifelong complications associated with lupus.",
keywords = "Adolescents, Chronic kidney disease, Glomerulonephritis, Health-related quality of life, Pediatric, Psychosocial",
author = "Andrea Knight and Kogon, {Amy J.} and Matheson, {Matthew B.} and Warady, {Bradley A.} and Furth, {Susan L.} and Hooper, {Stephen R.}",
year = "2017",
doi = "10.1016/j.jpeds.2017.06.044",
language = "English (US)",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Cognitive Function in Children with Lupus Nephritis

T2 - A Cross-Sectional Comparison with Children with Other Glomerular Chronic Kidney Diseases

AU - Knight, Andrea

AU - Kogon, Amy J.

AU - Matheson, Matthew B.

AU - Warady, Bradley A.

AU - Furth, Susan L.

AU - Hooper, Stephen R.

PY - 2017

Y1 - 2017

N2 - Objective: To identify factors contributing to cognitive impairment in children with lupus nephritis. Study design: A cross-sectional analysis of a large multicenter national cohort of children with chronic kidney disease (CKD) using standardized measures to determine baseline neuropsychiatric function and health-related quality of life (HRQoL) in children with lupus nephritis (n = 34), and to compare baseline function with that in children with other forms of glomerular CKD (gCKD; n = 171). We used inverse probability weighting via a logistic model for propensity score analysis to achieve balance between children with lupus nephritis and those with other glomerular causes of CKD, adjusting for known confounders. We used linear regression models to compare neurocognitive outcomes between exposure groups, adjusting for current prednisone use and testing for an interaction between current prednisone use and lupus nephritis, and to test for an association between cognitive function and HRQoL. Results: Current prednisone use was independently associated with worse attention (P < .01) and better adaptive skills (P = .04), and there was a significant interaction between current prednisone use and lupus nephritis for internalizing problems, with worse parent-reported internalizing problems in children with lupus nephritis on prednisone (P = .047). Better parent-reported HRQoL was associated with better visual memory (P = .01), and better child-reported HRQoL was associated with better attention (P < .01) and inhibitory control (P < .01). Both parent and child HRQoL were associated with better measures of executive function (P = .02 and < .001, respectively). Conclusion: Children with lupus nephritis have comparable or better cognitive function than their peers with other gCKDs, which is reassuring given the multiorgan and lifelong complications associated with lupus.

AB - Objective: To identify factors contributing to cognitive impairment in children with lupus nephritis. Study design: A cross-sectional analysis of a large multicenter national cohort of children with chronic kidney disease (CKD) using standardized measures to determine baseline neuropsychiatric function and health-related quality of life (HRQoL) in children with lupus nephritis (n = 34), and to compare baseline function with that in children with other forms of glomerular CKD (gCKD; n = 171). We used inverse probability weighting via a logistic model for propensity score analysis to achieve balance between children with lupus nephritis and those with other glomerular causes of CKD, adjusting for known confounders. We used linear regression models to compare neurocognitive outcomes between exposure groups, adjusting for current prednisone use and testing for an interaction between current prednisone use and lupus nephritis, and to test for an association between cognitive function and HRQoL. Results: Current prednisone use was independently associated with worse attention (P < .01) and better adaptive skills (P = .04), and there was a significant interaction between current prednisone use and lupus nephritis for internalizing problems, with worse parent-reported internalizing problems in children with lupus nephritis on prednisone (P = .047). Better parent-reported HRQoL was associated with better visual memory (P = .01), and better child-reported HRQoL was associated with better attention (P < .01) and inhibitory control (P < .01). Both parent and child HRQoL were associated with better measures of executive function (P = .02 and < .001, respectively). Conclusion: Children with lupus nephritis have comparable or better cognitive function than their peers with other gCKDs, which is reassuring given the multiorgan and lifelong complications associated with lupus.

KW - Adolescents

KW - Chronic kidney disease

KW - Glomerulonephritis

KW - Health-related quality of life

KW - Pediatric

KW - Psychosocial

UR - http://www.scopus.com/inward/record.url?scp=85024490384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024490384&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2017.06.044

DO - 10.1016/j.jpeds.2017.06.044

M3 - Article

C2 - 28734655

AN - SCOPUS:85024490384

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

ER -